Skip to main content

Advertisement

Log in

BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

This study was designed to explore the role of COPZ1 in breast cancer as well as discuss its specific reaction mechanism.

Methods

With the help of RT-qPCR and western blot, the expression of BMI1 and COPZ1 were measured. Then, the proliferation, colony formation and apoptosis were evaluated by CCK-8, colony formation and TUNEL assays, separately. Luciferase reporter assay and ChIP were applied to assess the relative activity of COPZ1 promoter as well as its binding with BMI1. Moreover, western blot was utilized to measure the expression of proliferation-, apoptosis- and autophagy-related proteins.

Results

According to GEPIA2 database, COPZ1 was upregulated in breast cancer tissues and was associated with the poor prognosis (P = 0.03). Results obtained from RT-qPCR and western blot verified that COPZ1 expression was greatly increased at both mRNA and protein levels in breast cancer cells as compared to control cells (P < 0.05 or P < 0.001). COPZ1 knockdown inhibited the proliferation, induced the autophagy and promoted the apoptosis of breast cancer cells. HumanTFDB predicted the binding sites of BMI1 and COPZ1. The increased relative luciferase activity of COPZ1 promoter following BMI1 overexpression (P < 0.001) and the binding of BMI1 with COPZ1 promoter indicated that BMI1 could activate COPZ1. Further experiments suggested that the effects of COPZ1 knockdown on the proliferation, apoptosis and autophagy of breast cancer cells were reversed by BMI1 overexpression, implying that BMI1 promoted the proliferation and repressed the autophagy of breast cancer cells via activating COPZ1.

Conclusions

To sum up, BMI1 exhibited promotive effects on the malignant progression of breast cancer through the activation of COPZ1. These findings might offer a preliminary theoretical basis for COPZ1 participation in autophagy in breast cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Najafi S, Sadeghi M, Abasvandi F, et al. Prognostic factors influencing prognosis in early breast cancer patients. Prz Menopauzalny. 2019;18(2):82–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.

    Article  Google Scholar 

  3. Torti SV, Torti FM. Cellular iron metabolism in prognosis and therapy of breast cancer. Crit Rev Oncog. 2013;18(5):435–48.

    Article  Google Scholar 

  4. Mayor S. Screening for early breast cancer reduces invasive cancer, study finds. BMJ. 2015;351: h6576.

    Article  Google Scholar 

  5. Majeed W, Aslam B, Javed I, et al. Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev. 2014;15(8):3353–8.

    Article  Google Scholar 

  6. Beck R, Rawet M, Wieland FT, et al. The COPI system: molecular mechanisms and function. FEBS Lett. 2009;583(17):2701–9.

    Article  CAS  Google Scholar 

  7. Razi M, Chan EY, Tooze SA. Early endosomes and endosomal coatomer are required for autophagy. J Cell Biol. 2009;185(2):305–21.

    Article  CAS  Google Scholar 

  8. Beller M, Sztalryd C, Southall N, et al. COPI complex is a regulator of lipid homeostasis. PLoS Biol. 2008;6(11): e292.

    Article  Google Scholar 

  9. Shtutman M, Baig M, Levina E, et al. Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit zeta 2 renders tumor cells dependent on its paralogous gene COPZ1. Proc Natl Acad Sci USA. 2011;108(30):12449–54.

    Article  CAS  Google Scholar 

  10. Huang X, Cho S, Spangrude GJ. Hematopoietic stem cells: generation and self-renewal. Cell Death Differ. 2007;14(11):1851–9.

    Article  CAS  Google Scholar 

  11. Bhattacharya R, Mustafi SB, Street M, et al. Bmi-1: at the crossroads of physiological and pathological biology. Genes Dis. 2015;2(3):225–39.

    Article  Google Scholar 

  12. Wang MC, Li CL, Cui J, et al. BMI-1, a promising therapeutic target for human cancer. Oncol Lett. 2015;10(2):583–8.

    Article  CAS  Google Scholar 

  13. Ren H, Du P, Ge Z, et al. TWIST1 and BMI1 in cancer metastasis and chemoresistance. J Cancer. 2016;7(9):1074–80.

    Article  CAS  Google Scholar 

  14. Chang J, Hu X, Nan J, et al. HOXD9induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelialmesenchymal transformation. Mol Med Rep. 2021. https://doi.org/10.3892/mmr.2021.12459.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jurikova M, Danihel L, Polak S, et al. Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 2016;118(5):544–52.

    Article  CAS  Google Scholar 

  16. Kaczanowski S. Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging. Phys Biol. 2016;13(3): 031001.

    Article  Google Scholar 

  17. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015;34(7):856–80.

    Article  CAS  Google Scholar 

  18. Zhang Y, Kong Y, Ma Y, et al. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene. 2021;40(8):1425–39.

    Article  CAS  Google Scholar 

  19. Di Marco T, Bianchi F, Sfondrini L, et al. COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death. Cancer Lett. 2020;476:106–19.

    Article  Google Scholar 

  20. Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66(12):6225–32.

    Article  CAS  Google Scholar 

  21. Dey A, Mustafi SB, Saha S, et al. Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy. 2016;12(4):659–70.

    Article  CAS  Google Scholar 

  22. Gergely JE, Dorsey AE, Dimri GP, et al. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells. Mol Carcinog. 2018;57(7):831–41.

    Article  CAS  Google Scholar 

Download references

Funding

This project is funded by Fund for Distinguished Young Scholars of 900 Hospital (No. 2021JQ08) and Starup Fund for Scientific Research, Fujian Medical University (No. 2020QH1250).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaixiang Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, S., Li, H., Chen, S. et al. BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1. Clin Transl Oncol 24, 2166–2174 (2022). https://doi.org/10.1007/s12094-022-02869-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-022-02869-w

Keywords

Navigation